• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲的乳腺癌筛查潜力。

The potential of breast cancer screening in Europe.

机构信息

Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

National Institute for Health Development, Tallinn, Estonia.

出版信息

Int J Cancer. 2021 Jan 15;148(2):406-418. doi: 10.1002/ijc.33204. Epub 2020 Jul 30.

DOI:10.1002/ijc.33204
PMID:32683673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7754503/
Abstract

Currently, all European countries offer some form of breast cancer screening. Nevertheless, disparities exist in the status of implementation, attendance and the extent of opportunistic screening. As a result, breast cancer screening has not yet reached its full potential. We examined how many breast cancer deaths could be prevented if all European countries would biennially screen all women aged 50 to 69 for breast cancer. We calculated the number of breast cancer deaths already prevented due to screening as well as the number of breast cancer deaths which could be additionally prevented if the total examination coverage (organised plus opportunistic) would reach 100%. The calculations are based on total examination coverage in women aged 50 to 69, the annual number of breast cancer deaths for women aged 50 to 74 and the maximal possible mortality reduction from breast cancer, assuming similar effectiveness of organised and opportunistic screening. The total examination coverage ranged from 49% (East), 62% (West), 64% (North) to 69% (South). Yearly 21 680 breast cancer deaths have already been prevented due to mammography screening. If all countries would reach 100% examination coverage, 12 434 additional breast cancer deaths could be prevented annually, with the biggest potential in Eastern Europe. With maximum coverage, 23% of their breast cancer deaths could be additionally prevented, while in Western Europe it could be 21%, in Southern Europe 15% and in Northern Europe 9%. Our study illustrates that by further optimising screening coverage, the number of breast cancer deaths in Europe can be lowered substantially.

摘要

目前,所有欧洲国家都提供某种形式的乳腺癌筛查。然而,在实施情况、参与程度和机会性筛查程度方面存在差异。因此,乳腺癌筛查尚未发挥其全部潜力。我们研究了如果所有欧洲国家都对 50 至 69 岁的所有女性每两年进行一次乳腺癌筛查,那么有多少乳腺癌死亡可以预防。我们计算了已经通过筛查预防的乳腺癌死亡人数,以及如果总检查覆盖率(有组织的加机会性的)达到 100%,可以额外预防的乳腺癌死亡人数。这些计算基于 50 至 69 岁女性的总检查覆盖率、50 至 74 岁女性每年的乳腺癌死亡人数以及假设组织性和机会性筛查同样有效的情况下乳腺癌死亡率最大可能降低的情况。总检查覆盖率从东部的 49%(东欧)、西部的 62%、北部的 64%到南部的 69%不等。每年已经有 21680 例乳腺癌死亡是通过乳房 X 线照相术筛查预防的。如果所有国家都达到 100%的检查覆盖率,每年可以额外预防 12434 例乳腺癌死亡,东欧的潜力最大。在最大覆盖率的情况下,其乳腺癌死亡人数可额外减少 23%,而在西欧为 21%,在南欧为 15%,在北欧为 9%。我们的研究表明,通过进一步优化筛查覆盖率,可以大大降低欧洲的乳腺癌死亡人数。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e1/7754503/623328fef991/IJC-148-406-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e1/7754503/65da1eccd59b/IJC-148-406-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e1/7754503/1613b54bfaaf/IJC-148-406-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e1/7754503/623328fef991/IJC-148-406-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e1/7754503/65da1eccd59b/IJC-148-406-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e1/7754503/1613b54bfaaf/IJC-148-406-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e1/7754503/623328fef991/IJC-148-406-g003.jpg

相似文献

1
The potential of breast cancer screening in Europe.欧洲的乳腺癌筛查潜力。
Int J Cancer. 2021 Jan 15;148(2):406-418. doi: 10.1002/ijc.33204. Epub 2020 Jul 30.
2
Evidence for reducing cancer-specific mortality due to screening for breast cancer in Europe: A systematic review.欧洲乳腺癌筛查降低癌症特异性死亡率的证据:系统评价。
Eur J Cancer. 2020 Mar;127:191-206. doi: 10.1016/j.ejca.2019.12.010. Epub 2020 Jan 10.
3
Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.北欧国家癌症筛查对截至2017年的死亡、成本和生活质量的影响。
Acta Oncol. 1997;36 Suppl 9:1-60.
4
Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.新西兰的乳腺X线筛查服务与乳腺癌死亡率:一项1999 - 2011年的全国队列研究
Br J Cancer. 2017 Mar 14;116(6):828-839. doi: 10.1038/bjc.2017.6. Epub 2017 Feb 9.
5
[Population-based breast cancer screening is not worthwhile. Screening has little effect on mortality].基于人群的乳腺癌筛查并不值得。筛查对死亡率几乎没有影响。
Ned Tijdschr Geneeskd. 2011;155(35):A3774.
6
Quality-of-life effects of screening mammography in Norway.挪威筛查性乳房 X 光摄影对生活质量的影响。
Int J Cancer. 2020 Apr 15;146(8):2104-2112. doi: 10.1002/ijc.32539. Epub 2019 Sep 6.
7
Development of breast cancer mortality considering the implementation of mammography screening programs - a comparison of western European countries.考虑到乳腺癌筛查计划的实施,乳腺癌死亡率的发展——西欧国家的比较。
BMC Public Health. 2019 Jun 26;19(1):823. doi: 10.1186/s12889-019-7166-6.
8
[Participation rates in the third round (2006-2007) of the breast cancer screening program in Hungary].[匈牙利乳腺癌筛查项目第三轮(2006 - 2007年)的参与率]
Magy Onkol. 2013 Sep;57(3):140-6. Epub 2013 Aug 9.
9
Breast cancer deaths averted over 3 decades.乳腺癌死亡人数在过去 30 年中得以避免。
Cancer. 2019 May 1;125(9):1482-1488. doi: 10.1002/cncr.31954. Epub 2019 Feb 11.
10
Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database.不同筛查水平但治疗可及性相似的欧洲邻国的乳腺癌死亡率:世卫组织死亡率数据库的趋势分析。
BMJ. 2011 Jul 28;343:d4411. doi: 10.1136/bmj.d4411.

引用本文的文献

1
Predicting the quality of digital mammography from the perspective of detectability of microcalcifications: A Radiomics approach.从微钙化灶可检测性角度预测数字化乳腺摄影质量:一种放射组学方法。
Med Phys. 2025 Aug;52(8):e18061. doi: 10.1002/mp.18061.
2
A psychometric analysis for the adaptation of the comprehensive breast cancer knowledge test for the male population: a methodological study.针对男性群体改编综合乳腺癌知识测试的心理测量学分析:一项方法学研究。
Front Public Health. 2025 Jul 23;13:1535564. doi: 10.3389/fpubh.2025.1535564. eCollection 2025.
3
Breast cancer screening coverage is severely reduced among women who reside in segregated areas: a cross-sectional investigation in Hungary.

本文引用的文献

1
Evidence for reducing cancer-specific mortality due to screening for breast cancer in Europe: A systematic review.欧洲乳腺癌筛查降低癌症特异性死亡率的证据:系统评价。
Eur J Cancer. 2020 Mar;127:191-206. doi: 10.1016/j.ejca.2019.12.010. Epub 2020 Jan 10.
2
A health systems approach to identifying barriers to breast cancer screening programmes. Methodology and application in six European countries.一种识别乳腺癌筛查项目障碍的卫生系统方法。在六个欧洲国家的方法学和应用。
Health Policy. 2018 Nov;122(11):1198-1205. doi: 10.1016/j.healthpol.2018.08.003. Epub 2018 Aug 24.
3
Identifying the barriers to effective breast, cervical and colorectal cancer screening in thirty one European countries using the Barriers to Effective Screening Tool (BEST).
居住在隔离区域的女性中乳腺癌筛查覆盖率大幅降低:匈牙利的一项横断面调查。
Front Public Health. 2025 Jul 14;13:1500098. doi: 10.3389/fpubh.2025.1500098. eCollection 2025.
4
Proteostasis Disruption by Proteasome Inhibitor MG132 and Propolin G Induces ER Stress- and Autophagy-Mediated Apoptosis in Breast Cancer.蛋白酶体抑制剂MG132和Propolin G破坏蛋白质稳态诱导乳腺癌中内质网应激和自噬介导的凋亡。
Food Sci Nutr. 2025 Jul 13;13(7):e70632. doi: 10.1002/fsn3.70632. eCollection 2025 Jul.
5
Global and regional trends in male breast cancer burden: a comparative analysis of incidence, prevalence, mortality, and disability-adjusted life years in China and worldwide (1990-2021).男性乳腺癌负担的全球和区域趋势:中国与全球(1990 - 2021年)发病率、患病率、死亡率及伤残调整生命年的比较分析
Gland Surg. 2025 May 30;14(5):818-833. doi: 10.21037/gs-2025-10. Epub 2025 May 26.
6
Cost-effectiveness of expanding the target population of biennial screening for breast cancer from ages 50-69 to 45 and/or 74: A cohort modelling study in the Finnish setting.将乳腺癌两年一次筛查的目标人群从50至69岁扩大到45岁和/或74岁的成本效益:芬兰背景下的队列建模研究
Health Econ Rev. 2025 Apr 11;15(1):35. doi: 10.1186/s13561-025-00628-5.
7
Assessing personal and health system barriers to breast cancer early diagnosis practices for women over 20 years old in Cluj-Napoca, Romania.评估罗马尼亚克鲁日-纳波卡市20岁以上女性乳腺癌早期诊断实践中的个人和卫生系统障碍。
Med Pharm Rep. 2025 Jan;98(1):118-124. doi: 10.15386/mpr-2694. Epub 2025 Jan 31.
8
Impact of Online Interactive Decision Tools on Women's Decision-Making Regarding Breast Cancer Screening: Systematic Review and Meta-Analysis.在线交互式决策工具对女性乳腺癌筛查决策的影响:系统评价与荟萃分析
J Med Internet Res. 2025 Jan 29;27:e65974. doi: 10.2196/65974.
9
The Five-Year Outcomes of Breast Cancer Surgical Management at the Colentina Surgical Clinic, Bucharest, Romania: A Descriptive Retrospective Analysis Between 2019 and 2023.罗马尼亚布加勒斯特科伦蒂纳外科诊所乳腺癌手术治疗的五年结果:2019年至2023年的描述性回顾性分析
Life (Basel). 2025 Jan 14;15(1):92. doi: 10.3390/life15010092.
10
Cancer awareness across borders: a comparative study of internet search trends for breast and prostate cancer in Europe and Turkey.跨国界的癌症认知:欧洲和土耳其乳腺癌与前列腺癌互联网搜索趋势的比较研究
BMC Cancer. 2024 Dec 20;24(1):1563. doi: 10.1186/s12885-024-13346-8.
利用有效的筛查工具(BEST)识别 31 个欧洲国家在乳腺癌、宫颈癌和结直肠癌筛查方面存在的障碍。
Health Policy. 2018 Nov;122(11):1190-1197. doi: 10.1016/j.healthpol.2018.08.004. Epub 2018 Aug 27.
4
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018.欧洲癌症发病率和死亡率模式:2018 年 40 个国家和 25 种主要癌症的估计值。
Eur J Cancer. 2018 Nov;103:356-387. doi: 10.1016/j.ejca.2018.07.005. Epub 2018 Aug 9.
5
Status of implementation and organization of cancer screening in The European Union Member States-Summary results from the second European screening report.欧盟成员国癌症筛查的实施与组织状况——第二次欧洲筛查报告的总结结果
Int J Cancer. 2018 Jan 1;142(1):44-56. doi: 10.1002/ijc.31043. Epub 2017 Oct 10.
6
Clarifying the debate on population-based screening for breast cancer with mammography: A systematic review of randomized controlled trials on mammography with Bayesian meta-analysis and causal model.用乳腺钼靶进行基于人群的乳腺癌筛查辩论的澄清:一项对乳腺钼靶随机对照试验的系统评价,采用贝叶斯荟萃分析和因果模型
Medicine (Baltimore). 2017 Jan;96(3):e5684. doi: 10.1097/MD.0000000000005684.
7
Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study.英国和威尔士截至2005年的人群乳腺癌筛查对乳腺癌死亡率的影响:一项个体水平队列研究。
Br J Cancer. 2017 Jan 17;116(2):246-252. doi: 10.1038/bjc.2016.415. Epub 2016 Dec 8.
8
Impact of organised mammography screening on breast cancer mortality in a case-control and cohort study.一项病例对照与队列研究中组织性乳腺钼靶筛查对乳腺癌死亡率的影响。
Br J Cancer. 2016 Apr 26;114(9):1038-44. doi: 10.1038/bjc.2016.68. Epub 2016 Mar 24.
9
Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 U.S. Preventive Services Task Force Recommendation.乳腺癌筛查的效果:系统评价和荟萃分析以更新 2009 年美国预防服务工作组的建议。
Ann Intern Med. 2016 Feb 16;164(4):244-55. doi: 10.7326/M15-0969. Epub 2016 Jan 12.
10
Impact of Screening on Breast Cancer Mortality: The UK Program 20 Years On.筛查对乳腺癌死亡率的影响:20年后的英国项目
Cancer Epidemiol Biomarkers Prev. 2016 Mar;25(3):455-62. doi: 10.1158/1055-9965.EPI-15-0803. Epub 2015 Dec 8.